首页> 外文会议>IEEE International Conference on Bioinformatics and Biomedicine >Boosting 1H-MRS Alzheimer Diagnosis with Boosted Trees
【24h】

Boosting 1H-MRS Alzheimer Diagnosis with Boosted Trees

机译:增强树促进 1 H-MRS阿尔茨海默病诊断

获取原文

摘要

Nowdays, more and more attention has been attached to early-onset alzheimer's disease (EOAD). It is well known that the Presenilin-1 gene (PSEN1) penetrant mutation can cause EOAD, and subjects with the PSEN1 p.Glu280Ala (E280A) mutation are at high risk of EOAD. Sensitive to the the progress of dementia, the brain metabolites measured by proton magnetic resonance spectroscopy (1H-MRS) can be used as informative biomarkers of EOAD. In this work, we focus on designing an effective diagnosis framework for EOAD caused by E280A mutation through the combination of 1H-MRS biomarkers and machine learning techniques. Specifically, we utilize gradient boosting decision tree (GBDT), which is an advanced machine learning tool, to analyze the physiological characteristics of EOAD patients and E280A mutation carriers. According to the relative importance of each 1H-MRS variable provided by GBDT, informative brain metabolites are selected out as biomarkers of AD symptoms. Combining the 1H-MRS biomarkers with GBDT, our method can achieve desirable predictive performance.1MCI is the transitional state of AD, which involves early cognitive impairments [4].
机译:现在,早期的阿尔茨海默病(eoad)附加了越来越多的关注。众所周知,PRESENILIN-1基因(PSEN1)渗透突变可引起eaod,并且具有PSEN1P.GLU280A1A(E280A)突变的受试者处于高风险。对痴呆进展敏感,脑代谢物由质子磁共振光谱测量( 1 H-MRS)可用作eoad的信息丰富的生物标志物。在这项工作中,我们专注于通过组合设计E280A突变引起的EAOD eaod有效的诊断框架 1 H-MRS Biomarkers和机器学习技巧。具体而言,我们利用梯度升压决策树(GBDT),即先进的机器学习工具,分析EAD患者和E280A突变载体的生理特征。根据每个人的相对重要性 1 通过GBDT提供的H-MRS变量,提供信息性脑代谢物作为广告症状的生物标志物。结合了 1 H-MRS Biomarkers具有GBDT,我们的方法可以实现所需的预测性能。 1 MCI是广告的过渡状态,涉及早期认知障碍[4]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号